These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

54 related items for PubMed ID: 6259652

  • 1. Presence of 1,25-dihydroxy vitamin D receptor in normal and abnormal breast tissue.
    Eisman JA, Martin TJ, MacIntyre I.
    Prog Biochem Pharmacol; 1980; 17():143-50. PubMed ID: 6259652
    [Abstract] [Full Text] [Related]

  • 2. Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.
    Frampton RJ, Suva LJ, Eisman JA, Findlay DM, Moore GE, Moseley JM, Martin TJ.
    Cancer Res; 1982 Mar; 42(3):1116-9. PubMed ID: 6277475
    [Abstract] [Full Text] [Related]

  • 3. Normal and malignant breast tissue is a target organ for 1,25-(0H)2 vitamin D3.
    Eisman JA, Macintyre I, Martin TJ, Frampton RJ, King RJ.
    Clin Endocrinol (Oxf); 1980 Sep; 13(3):267-72. PubMed ID: 6260398
    [Abstract] [Full Text] [Related]

  • 4. Measurement of 1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and clinical indices.
    Freake HC, Abeyasekera G, Iwasaki J, Marcocci C, MacIntyre I, McClelland RA, Skilton RA, Easton DF, Coombes RC.
    Cancer Res; 1984 Apr; 44(4):1677-81. PubMed ID: 6322984
    [Abstract] [Full Text] [Related]

  • 5. Specific uptake of 1,25-dihydroxycholecalciferol by human chronic myeloid leukemia cells.
    Freake HC, Iwasaki J, McCarthy DM.
    Cancer Res; 1984 Aug; 44(8):3627-31. PubMed ID: 6331655
    [Abstract] [Full Text] [Related]

  • 6. 1,25-dihydroxyvitamin D3 and breast cancer.
    Eisman JA, Suva LJ, Frampton RJ.
    Aust N Z J Surg; 1984 Feb; 54(1):17-20. PubMed ID: 6326729
    [Abstract] [Full Text] [Related]

  • 7. Systematic search for 1 alpha,25-dihydroxy-vitamin D3 receptors in human breast carcinomas.
    Ulmann A, Brami M, Corcos D, Bader C, Delarue JC, Contesso G.
    Biomed Pharmacother; 1984 Feb; 38(4):204-8. PubMed ID: 6093907
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites.
    Frampton RJ, Omond SA, Eisman JA.
    Cancer Res; 1983 Sep; 43(9):4443-7. PubMed ID: 6307514
    [Abstract] [Full Text] [Related]

  • 9. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ, Gombart AF, Kwok SH, Park S, Koeffler HP.
    Oncogene; 2000 Oct 19; 19(44):5091-7. PubMed ID: 11042697
    [Abstract] [Full Text] [Related]

  • 10. Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines.
    Findlay DM, Michelangeli VP, Eisman JA, Frampton RJ, Moseley JM, MacIntyre I, Whitehead R, Martin TJ.
    Cancer Res; 1980 Dec 19; 40(12):4764-7. PubMed ID: 6254651
    [Abstract] [Full Text] [Related]

  • 11. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.
    J Endocrinol; 1997 Sep 19; 154 Suppl():S57-73. PubMed ID: 9379138
    [Abstract] [Full Text] [Related]

  • 12. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration.
    Murphy LJ, Murphy LC, Vrhovsek E, Sutherland RL, Lazarus L.
    Cancer Res; 1984 May 19; 44(5):1963-8. PubMed ID: 6324992
    [Abstract] [Full Text] [Related]

  • 13. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
    Dokoh S, Donaldson CA, Haussler MR.
    Cancer Res; 1984 May 19; 44(5):2103-9. PubMed ID: 6324995
    [Abstract] [Full Text] [Related]

  • 14. Frequency of 1,25-dihydroxyvitamin D3 receptor in human breast cancer.
    Eisman JA, Suva LJ, Sher E, Pearce PJ, Funder JW, Martin TJ.
    Cancer Res; 1981 Dec 19; 41(12 Pt 1):5121-4. PubMed ID: 6272989
    [Abstract] [Full Text] [Related]

  • 15. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW, Sergeev IN, Bishop JE, Okamura WH.
    Cancer Res; 1993 Sep 01; 53(17):3935-42. PubMed ID: 8395333
    [Abstract] [Full Text] [Related]

  • 16. Specific binding protein for 1,25-dihydroxyvitamin D3 in bovine mammary gland.
    Reinhardt TA, Conrad HR.
    Arch Biochem Biophys; 1980 Aug 01; 203(1):108-16. PubMed ID: 6250480
    [No Abstract] [Full Text] [Related]

  • 17. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S, Krishnan AV, Feldman D.
    Clin Cancer Res; 2000 Aug 01; 6(8):3371-9. PubMed ID: 10955825
    [Abstract] [Full Text] [Related]

  • 18. 1,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines.
    Colston K, Colston MJ, Fieldsteel AH, Feldman D.
    Cancer Res; 1982 Mar 01; 42(3):856-9. PubMed ID: 6895862
    [Abstract] [Full Text] [Related]

  • 19. Temperature-dependent alteration of 1,25-dihydroxy-vitamin D3 receptor macromolecules in MC3T3-E1 cells: affinity of hexafluoro analog of 1,25-dihydroxyvitamin D3, ST-630, for these forms.
    Tanaka M, Muramatsu M, Higuchi S, Otomo S.
    Res Commun Mol Pathol Pharmacol; 1994 Jul 01; 85(1):3-13. PubMed ID: 7953192
    [Abstract] [Full Text] [Related]

  • 20. 1,25-dihydroxyvitamin-D-receptor in breast cancer cells.
    Eisman JA, Martin TJ, MacIntyre I, Moseley JM.
    Lancet; 1994 Jul 01; 2(8156-8157):1335-6. PubMed ID: 92676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.